Dapsone Topical Gel + vehicle control — Competitive Intelligence Brief

Dapsone Topical Gel + vehicle control (Dapsone Topical Gel + vehicle control) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sulfone antimicrobial and anti-inflammatory agent. Area: Dermatology.

phase 3 Sulfone antimicrobial and anti-inflammatory agent Dihydropteroate synthase; neutrophil function modulation Dermatology Small molecule

Target snapshot

Dapsone Topical Gel + vehicle control (Dapsone Topical Gel + vehicle control) — Allergan. Dapsone is a sulfone antimicrobial and anti-inflammatory agent that inhibits bacterial folate synthesis and suppresses neutrophil function to reduce inflammation in acne.

Comparator set (3 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Dapsone Topical Gel + vehicle control TARGET	Dapsone Topical Gel + vehicle control	Allergan	phase 3	Sulfone antimicrobial and anti-inflammatory agent	Dihydropteroate synthase; neutrophil function modulation
Aczone Gel	Aczone Gel	Icahn School of Medicine at Mount Sinai	marketed	Sulfone antibiotic	Bacterial dihydropteroate synthase; neutrophil function modulation
dapsone gel vehicle	dapsone gel vehicle	Almirall, S.A.	phase 3	Sulfone antibiotic with anti-inflammatory properties	Dihydropteroate synthase; neutrophil function modulation
Dapsone gel, 5%	Dapsone gel, 5%	Vanderbilt University Medical Center	marketed	Sulfone antimicrobial and anti-inflammatory agent	Dihydrofolate reductase; neutrophil function modulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sulfone antimicrobial and anti-inflammatory agent class)

1. Allergan · 1 drug in this class
2. Vanderbilt University Medical Center · 1 drug in this class